CERO THERAPEUTICS HOLDINGS, INC. (CERO) earnings per share
Annual history
Fiscal years 2023 – 2024
USD / SHARE 2 PERIODS
| Period | End | Diluted | Filed |
|---|---|---|---|
| FY 2024 | 2024-12-31 | -$363.00 | 2025-04-15 |
| FY 2023 | 2023-12-31 | -$24972.80 | 2024-04-02 |
Quarterly history
Fiscal years 2023 – 2026
USD / SHARE 12 PERIODS
| Period | End | Diluted | Filed |
|---|---|---|---|
| Q1 2026 | 2026-03-31 | -$0.20 | 2026-05-15 |
| Q3 2025 | 2025-09-30 | -$9.10 | 2025-11-19 |
| Q2 2025 | 2025-06-30 | -$61.71 | 2025-08-22 |
| Q1 2025 | 2025-03-31 | -$31.82 | 2025-05-15 |
| Q3 2024 | 2024-09-30 | -$170.22 | 2024-11-20 |
| Q2 2024 | 2024-06-30 | -$302.32 | 2024-08-14 |
| Q1 2024 | 2024-03-31 | -$244.80 | 2024-05-17 |
| Q1 2024 | 2024-02-13 | -$1959.63 | 2024-05-17 |
| Q4 2023 | 2023-12-31 | -$23632.80 | 2024-04-02 |
| Q3 2023 | 2023-09-30 | -$300.00 | 2023-11-09 |
| Q2 2023 | 2023-06-30 | -$460.00 | 2023-08-14 |
| Q1 2023 | 2023-03-31 | -$540.00 | 2023-05-12 |
Methodology
Annual rows come from the filer's 10-K and Q1–Q3 rows from the matching 10-Q; Q4 is derived as full-year minus nine-month YTD because XBRL doesn't tag Q4 as its own period. EPS Basic and EPS Diluted are reported directly by the filer. Per-share values are split-adjusted to the current share count (2 split s since 2025).
For the exact XBRL concepts and formulas, see the methodology reference for EPS, FCF per share, the Q4 derivation, and split adjustment.
CERO CIK 0001870404 Source: EDGAR filings · all facts